News
Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...
Dailymotion on MSN52m
US FDA approves Gilead’s twice-yearly injection for HIV preventionThe US Food and Drug Administration approves Wednesday, June 18, Gilead Sciences lenacapavir, a twice-yearly injection, for ...
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...
“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.
The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The ...
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
15h
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical ...
The FDA has approved Yeztugo, a twice-yearly HIV injection by Gilead shown to virtually eliminate new infections.
And more pharma news updates from Pharmalittle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results